Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
3.330
+0.045 (1.37%)
At close: Jun 3, 2025, 4:00 PM
3.450
+0.120 (3.60%)
After-hours: Jun 3, 2025, 7:38 PM EDT
Puma Biotechnology Employees
Puma Biotechnology had 172 employees as of December 31, 2024. The number of employees decreased by 13 or -7.03% compared to the previous year.
Employees
172
Change (1Y)
-13
Growth (1Y)
-7.03%
Revenue / Employee
$1,352,959
Profits / Employee
$221,320
Market Cap
164.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PBYI News
- 25 days ago - Puma Biotechnology, Inc. (PBYI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Puma Biotechnology Reports First Quarter Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - GlobeNewsWire
- 5 weeks ago - Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Business Wire
- 5 weeks ago - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - Business Wire
- 2 months ago - Puma SE: Undervalued With Tailwinds Ahead - Seeking Alpha
- 2 months ago - Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Business Wire